Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 519

1.

Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone?

Badgett RG, Tanaka DJ, Hunt DK, Jelley MJ, Feinberg LE, Steiner JF, Petty TL.

Am J Med. 1993 Feb;94(2):188-96.

PMID:
8430714
2.

Should chest examination be reinstated in the early diagnosis of chronic obstructive pulmonary disease?

Oshaug K, Halvorsen PA, Melbye H.

Int J Chron Obstruct Pulmon Dis. 2013;8:369-77. doi: 10.2147/COPD.S47992. Epub 2013 Jul 31.

3.

Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease.

Straus SE, McAlister FA, Sackett DL, Deeks JJ; CARE-COAD2 Group. Clinical Assessment of the Reliability of the Examination-Chronic Obstructive Airways Disease.

J Gen Intern Med. 2002 Sep;17(9):684-8.

5.

A prospective evaluation of plain radiographic signs of chronic obstructive pulmonary disease.

Woodring JH, Phillips BA, West JW, Ulmer J, Cooper JK.

J Thorac Imaging. 1991 Apr;6(2):14-21.

PMID:
1856897
6.
7.

Comparison of spirometric changes in the response to bronchodilators of patients with asthma or chronic obstructive pulmonary disease.

Silvestri IC, Pereira CA, Rodrigues SC.

J Bras Pneumol. 2008 Sep;34(9):675-82. English, Portuguese.

8.

Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population.

Hvidsten SC, Storesund L, Wentzel-Larsen T, Gulsvik A, Lehmann S.

Clin Respir J. 2010 Jan;4(1):13-21. doi: 10.1111/j.1752-699X.2009.00137.x.

PMID:
20298413
9.

Chronic respiratory symptoms, von Willebrand factor and longitudinal decline in FEV1.

Chambers DC, Boldy DA, Ayres JG.

Respir Med. 1999 Oct;93(10):726-33.

PMID:
10581662
10.

Diagnostic management of chronic obstructive pulmonary disease.

Broekhuizen BD, Sachs AP, Hoes AW, Verheij TJ, Moons KG.

Neth J Med. 2012 Jan;70(1):6-11. Review.

11.

Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.

Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.

Am J Med. 1996 Jan 29;100(1A):40S-48S.

PMID:
8610716
13.

The clinical evaluation for diagnosing obstructive airways disease in high-risk patients.

Badgett RG, Tanaka DJ, Hunt DK, Jelley MJ, Feinberg LE, Steiner JF, Petty TL.

Chest. 1994 Nov;106(5):1427-31.

PMID:
7956395
14.

Prevalence of airflow limitation on medical check-up in Japanese subjects.

Omori H, Nonami Y, Mihara S, Marubayashi T, Morimoto Y, Aizawa H.

J UOEH. 2007 Sep 1;29(3):209-19.

PMID:
17900001
15.

Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.

Johannessen A, Omenaas ER, Bakke PS, Gulsvik A.

Thorax. 2005 Oct;60(10):842-7. Epub 2005 Aug 5.

16.
17.
18.

Risk factors for chronic obstructive pulmonary disease in a north Italian rural area.

Viegi G, Carrozzi L, Di Pede F, Baldacci S, Pedreschi M, Modena P, Paoletti P.

Eur J Epidemiol. 1994 Dec;10(6):725-31.

PMID:
7672054
19.

Diagnosing obstructive lung disease. Why is differentiating COPD from asthma important?

Subramanian D, Guntupalli KK.

Postgrad Med. 1994 Jun;95(8):69-70, 75-8, 83-5. Review.

PMID:
8202424
20.

Lung function during moderate hypobaric hypoxia in normal subjects and patients with chronic obstructive pulmonary disease.

Dillard TA, Rajagopal KR, Slivka WA, Berg BW, Mehm WJ, Lawless NP.

Aviat Space Environ Med. 1998 Oct;69(10):979-85.

PMID:
9773900
Items per page

Supplemental Content

Write to the Help Desk